HANSON KRISTOPHER (General Counsel) sold 7.3% of their position (13.92K shares) of MAPLIGHT THERAPEUTICS, INC. on the open market
Open‑market sale worth $388.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 5/7/2026ACC: 0001789970-26-000008
Officer· General Counsel
Since Feb 2026
-13.92K
Net shares
Net seller
$388.2K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
13.92K disposed
Non-Derivative Transactions4
Voting Common Stock
Direct
Shares
−9.03K
Price / share
$27.50
Trade value
$248.32K
% of position
4.7%
5/4/2026
190.16K→181.13K
Voting Common Stock
Direct
Shares
−3.91K
Price / share
$28.29
Trade value
$110.56K
% of position
2.2%
5/4/2026
181.13K→177.23K
Voting Common Stock
Direct
Shares
−296.00
Price / share
$29.56
Trade value
$8.75K
% of position
0.2%
5/4/2026
177.23K→176.93K
Voting Common Stock
Direct
Shares
−683.00
Price / share
$30.08
Trade value
$20.54K
% of position
0.4%
5/4/2026
176.93K→176.25K
Total
Net shares
−13.92K
Net value
-$388.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 5/4/2026 | S · Sale | −9.03K | $27.50 | $248.32K | 4.7% | 190.16K | 181.13K |
| Voting Common Stock Direct | 5/4/2026 | S · Sale | −3.91K | $28.29 | $110.56K | 2.2% | 181.13K | 177.23K |
| Voting Common Stock Direct | 5/4/2026 | S · Sale | −296.00 | $29.56 | $8.75K | 0.2% | 177.23K | 176.93K |
| Voting Common Stock Direct | 5/4/2026 | S · Sale | −683.00 | $30.08 | $20.54K | 0.4% | 176.93K | 176.25K |
| Total | −13.92K | -$388.18K | ||||||
Derivative Transactions0
No derivative transactions reported